PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Emergency Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.\', \'Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.\', \'Department of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.\', \'Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.\', \'Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/imj.15078
?:doi
?:hasPublicationType
?:journal
  • Internal medicine journal
is ?:pmid of
?:pmid
?:pmid
  • 33022124
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.748
?:rankingScore_hIndex
  • 60
is ?:relation_isRelatedTo_publication of
?:title
  • Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all